FROM FIRST QUESTION TO FOLLOW-UP
Explore how GLP-1 programs describe consultations, pharmacy services, delivery and ongoing support.
Who evaluates the history?
What exact product is proposed?
Who dispenses and ships?
Who answers clinical questions?
NEW SCIENTIFIC COVERAGE
SCIENTIFIC ARTICLE
Semaglutide reduced a major cardiovascular composite in people with established cardiovascular disease and no diabetes. Understanding the endpoint, absolute difference, and treatment discontinuations is essential to interpreting that benefit.
SCIENTIFIC ARTICLE
Semaglutide reduced a combined kidney and cardiovascular outcome in people with type 2 diabetes and chronic kidney disease. Understanding who entered FLOW—and what counted as an event—is essential to applying the result responsibly.
SCIENTIFIC ARTICLE
Randomized tirzepatide withdrawal separates maintaining a treatment effect from finishing a course. Reading its two baselines—and newer maintenance-dose research—shows what the evidence can and cannot tell patients changing care.
START READING
READING GUIDE
Real examples from six telehealth services show why clinical approval, insurance authorization, pharmacy fulfillment and ongoing care are separate steps—not one guaranteed transaction.
READING GUIDE
Canceling a subscription, canceling a pharmacy order and making a clinical treatment decision are different tasks. Six providers’ public documents show why each needs its own confirmation.
READING GUIDE
The brand on the website may coordinate your care without employing your prescriber. Here is how six GLP-1 platforms describe their medical groups, clinical professionals, pharmacies and support teams—and where their documentation leaves questions.
PROVIDER DIRECTORY
PROVIDER FILE
Washington clinic advertising compounded GLP-1 programs, statewide telehealth, pharmacy-direct delivery and body-composition support.
Look closer: Confirm clinical-network roles, remote scan access, itemized pricing, delivery procedures and cancellation terms.
PROVIDER FILE
Employer-oriented wellness platform connecting members with independent clinical practices and pharmacies for compounded GLP-1 access.
Look closer: Confirm product, state eligibility, assigned practice and pharmacy, full charges, follow-up access and both cancellation deadlines.
PROVIDER FILE
Physician-led medical and aesthetic practice advertising GLP-1 injections, eligibility screening and ongoing clinical support.
Look closer: Confirm the GLP-1 product, pharmacy, state access, follow-up schedule and itemized cost; $179/month is an aesthetic offer.
PROVIDER FILE
Online paid-intake service offering clinician-reviewed compounded GLP-1 programs through affiliated pharmacies.
Look closer: Confirm consultation access, pharmacy identity, state availability, shipping remedies and renewal/cancellation terms.
PROVIDER FILE
Self-pay telehealth weight-management membership linking OpenLoop clinical practices with independent pharmacy fulfillment.
Look closer: Confirm cancellation deadlines, checkout commitments, dispensing pharmacy and clinical-response arrangements.
PROVIDER FILE
GLP-1 evaluation through One Medical; separate prescription dispensing and delivery through Amazon Pharmacy.
Look closer: Confirm local clinical access, lab requirements, authorization responsibility, product-specific pricing and follow-up.
FROM FIRST QUESTION TO FOLLOW-UP
Use source-linked reporting to prepare better questions. A review can explain the published offer; a healthcare professional must evaluate your individual treatment options.
How we research →Who evaluates the history?
What exact product is proposed?
Who dispenses and ships?
Who answers clinical questions?